Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-13

Clinical Trial Update: Progression Delaying Effect of Escitalopram in Alzheimer's Disease [NA]

View source ↗

Summary

A completed clinical trial investigated whether escitalopram could delay progression in Alzheimer's disease; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Alzheimer's Disease | NA | Status: COMPLETED | Results posted: 2014-06-13